Use of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.
Jul 24, 2024
0
0
A new review in the Journal of Medical Internet Research found that community-dwelling older adults are more likely to continue using wearable monitoring devices (WMDs), like trackers, pedometers, and smartwatches, if they ...
Jun 21, 2024
0
1
The long, warm days of summer unlock countless opportunities for fun and make the school break a great time to re-calibrate family rules around screen use. UCSF Benioff Children's Hospital pediatrician and screen time researcher ...
Jun 21, 2024
0
0
A large, linked data study has detailed the scale of prescription opioid use—such as oxycodone, morphine, or tramadol—after a hospital or emergency department (ED) visit, while giving insight into how often people then ...
May 29, 2024
0
0
Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals' ...
Apr 29, 2024
0
11
Spring is in the air, and along with it loads of tree, grass and weed pollen.
Apr 9, 2024
0
0
DGIST Department of Robotics and Mechatronics Engineering Professor Kim Sohee and her research team have developed a highly durable brain electrode technology that uses soft and flexible materials. The technology is expected ...
Mar 29, 2024
0
22
New treatments for depression are needed that act rapidly and also have sustained effects. Ketamine accomplishes this, but toxic side effects limit its long-term use. Scientists haven't understood how ketamine was able to ...
Feb 29, 2024
0
1
High-intensity exercise induces brain-protective effects that have the potential to not just slow down but possibly reverse the neurodegeneration associated with Parkinson's disease, a new pilot study suggests.
Feb 27, 2024
0
241
Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22. This is one of the highest antidepressant prescribing rates in the world.
Feb 9, 2024
0
11
